Adults with cystic fibrosis experience higher pain prevalence and severity compared to healthy controls, with significant unmet needs in pain management. New study highlights critical gaps in care.
Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...
With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...
Receiving a diagnosis for any disease/condition is not an easy experience. One organization hopes to make patients newly diagnosed with pulmonary fibrosis feel supported during this time via a new ...
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and often fatal lung disease characterized by the scarring (fibrosis) of lung tissue, ...
When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...
Power has now been restored to over 215,000 properties. Speaking on Good Morning Ulster, Ronan McKeown, NIE future networks ...
If you receive a denial letter from your insurer, don’t appeal the decision before seeking legal advice, says a leading ...
Abbie Stockard declared victory over 51 other contestants. She credited her relationship with God for giving her the drive to ...
The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...
Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...
Hollywood attorney Bryan Freedman previously represented Travis Flores, who accused Baldoni of stealing ideas from an ...